Regeneron Pharmaceuticals (REGN) Q1 2018 Results - Earnings Call Transcript

5/4/18

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2018 Earnings Call May 3, 2018 8:30 AM ET

Executives

Manisha A. Narasimhan - Regeneron Pharmaceuticals, Inc.

Leonard S. Schleifer - Regeneron Pharmaceuticals, Inc.

George Damis Yancopoulos - Regeneron Pharmaceuticals, Inc.

Marion McCourt - Regeneron Pharmaceuticals, Inc.

Robert E. Landry - Regeneron Pharmaceuticals, Inc.

Analysts

Ying Huang - Bank of America Merrill Lynch

Carter Gould - UBS Securities LLC

Terence Flynn - Goldman Sachs & Co. LLC

Geoffrey C. Porges - Leerink Partners LLC

Matthew K. Harrison - Morgan Stanley & Co. LLC

Phil Nadeau - Cowen & Co. LLC

Cory W. Kasimov - JPMorgan Securities LLC

Geoff Meacham - Barclays Capital, Inc.

Operator

Welcome to the Regeneron Pharmaceuticals First Quarter 2018 Earnings Conference Call. My name is Jason and I will be your operator. At this time all participants will be in a listen-only mode. Later, we will have a question-and-answer session. Also, please note this conference is being recorded.

And I will now turn the call over to Manisha Narasimhan, Head of Investor Relations. You may begin.

READ FULL ARTICLE HERE